Structural studies of several clinically important oncology drugs in complex with human serum albumin

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 12, 2013, Pages 5356-5374

  Wang, Zhong Min ^a   Ho, Joseph X ^a   Ruble, John R ^a   Rose, John ^b   Rüker, Florian ^c   Ellenburg, Melanie ^a   Murphy, Robert ^a   Click, James ^a   Soistman, Elizabeth ^a   Wilkerson, Leslie ^a   Carter, Daniel C ^a  

^a New Century Pharmaceuticals Incorporated   (United States)

^b University of Georgia ^*  (United States)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Anticancer drug; Drug design; Human serum albumin; Oncology; Structure; Subdomain IB

Indexed keywords

9 AMINOCAMPTOTHECIN; ANTINEOPLASTIC AGENT; BICALUTAMIDE; CAMPTOTHECIN; ETOPOSIDE; HUMAN SERUM ALBUMIN; IDARUBICIN; POLYPEPTIDE; TENIPOSIDE;

ALPHA HELIX; ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG BINDING SITE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; HYDROGEN BOND; HYDROPHOBICITY; INTERNALIZATION; LOW TEMPERATURE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 85028125410     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.06.03     Document Type: Article

References (47)

1. T. Peters Jr. All about Albumin: Biochemistry, Genetics and Medical Applications 1996 Academic Press 95 97
2. C. Chaudhury Albumin binding to FcRn: distinct from the FcRn-IgG interaction Biochemistry 45 15 2006 4983 4990
3. X.M. He, and D.C. Carter Atomic structure and chemistry of human serum albumin Nature 358 1992 209 215
4. D.C. Carter, and J. Ho Structure of serum albumin Adv. Protein Chem. 45 1994 153 203
5. R. Brodersen Bilirubin. Solubility and interaction with albumin and phospholipid J. Biol. Chem. 254 7 1979 2364 2369
6. D.C. Carter Crystallographic survey of albumin drug interaction and preliminary applications in cancer chemotherapy Burger's Medicinal Chemistry, Drug Discovery and Development 7th edition 2010 John Wiley and Sons 437 468
7. S. Curry Lessons from the crystallographic analysis of small molecule binding to human serum albumin Drug Metab. Pharmacokinet. 24 4 2009 342 357
8. C. Pisano Clinical trials with pegylated liposomal doxorubicin in the treatment of ovarian cancer J. Drug Deliv. 2013 2013 898146
9. X. Zhang PEGylated nanostructured lipid carriers loaded with 10â€hydroxycamptothecin: an efficient carrier with enhanced antiâ€tumour effects against lung cancer J. Pharm. Pharmacol. 60 8 2008 1077 1087
10. U. Martinowitz, and A. Lubetsky Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B Thromb. Res. 131 2013 S11 S14
11. M. Dockal, D.C. Carter, and F. Rüker The three recombinant domains of human serum albumin structural characterization and ligand binding properties J. Biol. Chem. 274 41 1999 29303 29310
12. M. Dockal Five recombinant fragments of human serum albumin - tools for the characterization of the warfarin binding site Protein Sci. 9 8 2000 1455 1465
13. M. Wardell The atomic structure of human methemalbumin at 1.9 Å Biochem. Biophys. Res. Commun. 291 4 2002 813 819
14. G. Sudlow, D. Birkett, and D. Wade Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12 6 1976 1052 1061
15. N. Mast Binding of a cyano-and fluoro-containing drug bicalutamide to cytochrome P450 46A1 unusual features and spectral response J. Biol. Chem. 288 7 2013 4613 4624
16. D.C. Carter Preliminary crystallographic studies of four crystal forms of serum albumin Eur. J. Biochem. 226 3 1994 1049 1052
17. S. Sugio Crystal structure of human serum albumin at 2.5 Å resolution Protein Eng. 12 6 1999 439 446
18. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. A276 1997 307 326
19. D.C. Carter Three-dimensional structure of human serum albumin Science 244 4909 1989 1195 1198
20. P. Fitzgerald MERLOT, an integrated package of computer programs for the determination of crystal structures by molecular replacement J. Appl. Crystallogr. 21 3 1988 273 278
21. P.D. Adams PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr. D Biol. Crystallogr. 66 2 2010 213 221
22. P. Emsley Features and development of Coot Acta Crystallogr. D Biol. Crystallogr. 66 4 2010 486 501
23. P.V. Afonine Towards automated crystallographic structure refinement with phenix. refine Acta Crystallogr. D Biol. Crystallogr. 68 4 2012 352 367
24. M.D. Winn, M.N. Isupov, and G.N. Murshudov Use of TLS parameters to model anisotropic displacements in macromolecular refinement Acta Crystallogr. D 57 1 2001 122 133
25. V.B. Chen MolProbity: all-atom structure validation for macromolecular crystallography Acta Crystallogr. D Biol. Crystallogr. 66 1 2009 12 21
26. A.C. Wallace, R.A. Laskowski, and J.M. Thornton LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions Protein Eng. 8 2 1995 127 134
27. S. McNicholas Presenting your structures: the CCP4mg molecular-graphics software Acta Crystallogr. D Biol. Crystallogr. 67 Pt 4 2011 386 394
28. E.F. Pettersen UCSF Chimera - a visualization system for exploratory research and analysis J. Comput. Chem. 25 13 2004 1605 1612
29. H.M. Berman The protein data bank Nucleic Acids Res. 28 1 2000 235 242
30. M.E. Wall Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata 1, 2 J. Am. Chem. Soc. 88 16 1966 3888 3890
31. W. DeWys, S. Humphreys, and A. Goldin Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma Cancer Chemother. Rep. 1 52 2 1968 229 242
32. J.A. Gottlieb Treatment of malignant melanoma with camptothecin (NSC-100880) Cancer Chemother. Rep. 56 1972 103 105
33. F.M. Muggia Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies Cancer Chemother. Rep. 1 56 4 1972 515 521
34. C. Moertel Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer Cancer Chemother. Rep. 1 56 4 1972 551 552
35. B.C. Giovanella DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts Science 246 4933 1989 1046 1048
36. Z. Mi, and T.G. Burke Differential interactions of camptothecin lactone and carboxylate forms with human blood components Biochemistry 33 34 1994 10325 10336
37. Z. Mi, and T.G. Burke Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study Biochemistry 33 42 1994 12540 12545
38. F. Arcamone Properties of antitumor anthracyclines and new developments in their application: Cain Memorial Award Lecture Cancer Res. 45 12 Part 1 1985 5995 5999
39. R.T. Chlebowski Adriamycin (doxorubicin) cardiotoxicity: a review West. J. Med. 131 5 1979 364
40. G.A. Jeffrey, and W. Saenger Hydrogen Bonding in Biological Structures 1994 Springer-Verlag Berlin
41. M. Menozzi Selfâ€association of doxorubicin and related compounds in aqueous solution J. Pharm. Sci. 73 6 1984 766 770
42. M. Gordaliza Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives Toxicon 44 4 2004 441 459
43. P.A. Zunszain Crystallographic analysis of human serum albumin complexed with 4Z,15E-Bilirubin-IXα J. Mol. Biol. 381 2 2008 394 406
44. Z. Zhou The androgen receptor: an overview Recent Prog. Horm. Res. 49 1994 249
45. M. Tsai, and B.W. O'Malley Molecular mechanisms of action of steroid/thyroid receptor superfamily members Annu. Rev. Biochem. 63 1 1994 451 486
46. W. Gao, J. Kim, and J.T. Dalton Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands Pharm. Res. 23 8 2006 1641 1658
47. N. Takahashi, Y. Takahashi, T. Isobe, F.W. Putnam, M. Fujita, C. Satoh, and J.V. Neel Amino acid substitution in inherited albumin variants form the Amerindian and Japanese populations Proc. Natl. Acad. Sci. 84 1987 8001 8005